Navigation Links
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
Date:2/24/2009

2007 ---- ---- Net cash provided by operating activities $91,437 $122,867 Net cash provided by (used in) Investing activities 15,440 (216,176) Net cash (used in)/provided by financing activities (10,070) 221,471 Selected Consolidated Balance Sheet Data December 31, December 31, (in thousands) 2008 2007 ---- ---- Assets Current assets: Cash and cash equivalents $275,839 $179,691 Short-term investments - 404,637 Deferred income taxes 26,785 7,983 Total current assets 356,445 622,773 Intangible assets, net 639,693 122,502 Goodwill 34,787 - Deferred income taxes 91,757 12,312 Total assets 1,147,574 776,066 Liabilities and Stockholders' Equity Total current liabilities $51,086 $28,370 Deferred tax liabilities 181,392 - Long-term debt 250,000 250,000 Total liabilities 486,550 279,503 Total stockholders' equity 661,024 496,563 Total liabilities and stockholders' equity 1,147,574 776,066


'/>"/>
SOURCE ViroPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. ViroPharma to Present at Three November Healthcare Conferences
2. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
3. ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008
4. ViroPharma to Present at Three October Healthcare Conferences
5. ViroPharma to Present at Three September Healthcare Conferences
6. ViroPharma To Acquire Lev Pharmaceuticals
7. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
8. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
9. ViroPharma to Present at Two Upcoming Healthcare Conferences
10. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
11. ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... 31, 2015 , ... Ralco is honored to announce that it is the ... be held August 5-9 in Marshall. The Ralco Enrichment Center is an interactive experience ... agriculture impacts their daily lives. This unique exhibit also features a birthing center for ...
(Date:7/30/2015)... 30, 2015   GenoSpace , a leading ... and analysis of genomic and other biomedical data, ... joined the company as Vice President of Sales ... "GenoSpace partners with its ... analyze and explore complex sets of genomic, phenotypic ...
(Date:7/30/2015)... ... July 30, 2015 , ... The 2015 Market Research Report on ... current state of the global Propanol market with a focus on the Chinese situation. ... Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang ...
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... ... successful completion of a field clinical study of its canine osteoarthritis stem cell ... with Aratana Therapeutics (Kansas City, KS) and will be marketed in the US ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3
... CRY ), an implantable biological medical ... quarter financial results will be released on Thursday, April 30, ... teleconference call and live webcast at 10:00 a.m. Eastern Time ... session hosted by Steven G. Anderson, president and chief executive ...
... FACP, CPE TO JOIN NEOSTEM,S ADVISORY BOARDNEW YORK, April ... ), which is pioneering the pre-disease collection, processing and ... need, today announced that it will be moving its ... utilizing exclusively Progenitor Cell Therapy, LLC (PCT), a leading ...
... leading peer-reviewed research journal, is partnering with Applied Biosystems, a division ... Cancer Genomics to be broadcast live online at 12 noon ET ... ... 15, 2009 -- The business office of Science, the world,s leading ...
Cached Biology Technology:CryoLife Announces Release Date and Teleconference Call Details for 2009 First Quarter Financial Results 2NeoStem, Inc. Announces Agreement With Progenitor Cell Therapy, LLC 2NeoStem, Inc. Announces Agreement With Progenitor Cell Therapy, LLC 3Science Magazine to Host Webinar on Advances in Cancer Genomics 2Science Magazine to Host Webinar on Advances in Cancer Genomics 3
(Date:7/7/2015)... MOUNTAIN VIEW, Calif. , July 7, 2015 ... mobile biometrics market, Frost & Sullivan recognizes Credence ... & Sullivan Entrepreneurial Company of the Year ... product suite to aid in its mission of ... and under-recognized populations globally. As Credence ID was ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ) has ... Market by Application, Technology, Function & Geography - Global ... The next generation biometrics market is expected to ... 17.9% between 2015 and 2020 Travel & ... Safran SA ( France ), NEC ...
(Date:6/30/2015)... , June 30, 2015 Genisphere ... as CEO to help further develop Genisphere,s therapeutics capabilities ... partnering experience, having spent much of the last 25 ... Amgen, Baxter Bioscience, and Johnson & Johnson. Tom started ... Technology and Biotech Corporate Finance. He graduated from Dartmouth ...
Breaking Biology News(10 mins):Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... The Origin of Species 150 years ago, he deliberately avoided ... the mention of the ,Creator, in the last paragraph of ... to commit on the matter. An international team, led by ... that idea and shows that the British naturalist did explain ...
... 27, 2009 UT Southwestern Medical Center patient Michael LeBlanc, ... newest generation of a mechanical device designed to improve heart ... heart transplant. Called a left-ventricular assist device (LVAD), its ... throughout the body. For Mr. LeBlanc, it will help his ...
... City, Ireland, October 26, 2009 Results of an ... intraocular lens (IOLs) at the time of cataract surgery ... afford protection against the development and/or progression of age-related ... and vision researchers from the Macular Pigment Research Group ...
Cached Biology News:Charles Darwin really did have advanced ideas about the origin of life 2UT Southwestern patient first in North Texas to receive newest-generation heart failure device 2UT Southwestern patient first in North Texas to receive newest-generation heart failure device 3Blue light-filtering increases macular pigment, may protect against age-related vision loss 2Blue light-filtering increases macular pigment, may protect against age-related vision loss 3Blue light-filtering increases macular pigment, may protect against age-related vision loss 4
... screening and binding optimization and built on ... synthesis platform. These microarrays are available as ... Service. Probe Content Our ... 1500 known aptamer sequences. Add up to ...
... LC Sciences provides a comprehensive service ... high density peptide microarrays synthesized on ... using recombinant proteins/antibodies or serum samples. ... your sequence designs, binding assays using ...
... a comprehensive epitope analysis service utilizing ... Paraflo microfluidic chips for immunological studies, ... comprehensive service includes assistance with your ... provided by you, single or dual ...
... aptamer screening and binding optimization and built ... on-chip synthesis platform. Thousands of customer specified ... LC Sciences can provide assistance with custom ... part of our comprehensive DNA/RNA Aptamer Microarray ...
Biology Products: